Blood test may predict death risk in ICU patients

NCT ID NCT07460141

Recruiting now Knowledge-focused Sponsor: Ezgi Günaydın Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing 42 postoperative patients in the intensive care unit to see if levels of a protein called IL-6 and other inflammation scores can predict who will die or have serious complications. Researchers will measure these markers at ICU arrival and 24 hours later, then track outcomes like death, infections, and time on a breathing machine. The goal is to find simple tools to identify high-risk patients early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict which postoperative ICU patients are at highest risk of death or complications, leading to earlier interventions.
What could go wrong: This is a small observational study (42 people) that only looks at existing data, so it cannot prove cause and effect. Results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Inflammation inflammatory disease Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS INFLAMMATION INTENSIVE CARE UNIT ADMISSION POSTOPERATIVE COMPLICATIONS

Blood test may predict death risk in ICU patients

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions